Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Makanga

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Malaria Journal|July 30, 2014
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionMichael Makanga
Malaria Journal|October 13, 2009
The clinical efficacy of artemether/lumefantrine (Coartem)Michael Makanga, Srivicha Krudsood
Current Opinion in Infectious Diseases|September 9, 2004
Falciparum malaria: current therapeutic challengesKathryn Maitland, Michael Makanga, Thomas N Williams
Expert Review of Anti-Infective Therapy|June 18, 2015
The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrineAbdoulaye A Djimde, Michael Makanga, Kelli Kuhen, et al.
Human Resources for Health|May 11, 2023
The abiding, hidden, and pervasive centrality of the health research workforcePaulo Ferrinho, Michael Makanga, Shabnum Sarfraz, et al.
Proteomics|April 16, 2005
Towards a proteomic definition of CoArtem action in Plasmodium falciparum malariaMichael Makanga, Patrick G Bray, Paul Horrocks, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
EU-Africa partnerships in health research from 2014 - 2023: Outputs and lessons learntDebora Bade, Andreia Coelho, Dominika Jajkowicz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 20, 2005
Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malariaCatherine Falade, Michael Makanga, Zul Premji, et al.
The Lancet. Infectious Diseases|March 3, 2022
Accelerating research and development of new vaccines against tuberculosis: a global roadmapFrank Cobelens, Rajinder Kumar Suri, Michelle Helinski, et al.
The American Journal of Tropical Medicine and Hygiene|June 9, 2006
Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient dataMichael Makanga, Zul Premji, Catherine Falade, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Malaria Journal|July 30, 2014
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionMichael Makanga
Malaria Journal|October 13, 2009
The clinical efficacy of artemether/lumefantrine (Coartem)Michael Makanga, Srivicha Krudsood
Current Opinion in Infectious Diseases|September 9, 2004
Falciparum malaria: current therapeutic challengesKathryn Maitland, Michael Makanga, Thomas N Williams
Expert Review of Anti-Infective Therapy|June 18, 2015
The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrineAbdoulaye A Djimde, Michael Makanga, Kelli Kuhen, et al.
Human Resources for Health|May 11, 2023
The abiding, hidden, and pervasive centrality of the health research workforcePaulo Ferrinho, Michael Makanga, Shabnum Sarfraz, et al.
Proteomics|April 16, 2005
Towards a proteomic definition of CoArtem action in Plasmodium falciparum malariaMichael Makanga, Patrick G Bray, Paul Horrocks, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
EU-Africa partnerships in health research from 2014 - 2023: Outputs and lessons learntDebora Bade, Andreia Coelho, Dominika Jajkowicz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 20, 2005
Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malariaCatherine Falade, Michael Makanga, Zul Premji, et al.
The Lancet. Infectious Diseases|March 3, 2022
Accelerating research and development of new vaccines against tuberculosis: a global roadmapFrank Cobelens, Rajinder Kumar Suri, Michelle Helinski, et al.
The American Journal of Tropical Medicine and Hygiene|June 9, 2006
Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient dataMichael Makanga, Zul Premji, Catherine Falade, et al.
Pageof 2